Log in

688393 Guangzhou LBP Medicine Science & Technology Co., Ltd. SSE · China

Guangzhou LBP Medicine Science & Technology Co. (688393) news

Guangzhou LBP Medicine Science & Technology Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688393, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Guangzhou LBP Medicine Science & Technology Co. news

We have not published a story on Guangzhou LBP Medicine Science & Technology Co. yet. When there is news, it will appear here.

Questions about Guangzhou LBP Medicine Science & Technology Co.

What is the ticker symbol of Guangzhou LBP Medicine Science & Technology Co.?

Guangzhou LBP Medicine Science & Technology Co., Ltd. trades under the ticker 688393 on SSE.

Where is Guangzhou LBP Medicine Science & Technology Co. listed?

Guangzhou LBP Medicine Science & Technology Co., Ltd. is listed on SSE.

Which country or territory is Guangzhou LBP Medicine Science & Technology Co. listed under?

Our directory records Guangzhou LBP Medicine Science & Technology Co., Ltd. under China.

What does Guangzhou LBP Medicine Science & Technology Co. do?

Our directory classifies Guangzhou LBP Medicine Science & Technology Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Guangzhou LBP Medicine Science & Technology Co.?

The ISIN recorded for Guangzhou LBP Medicine Science & Technology Co., Ltd. is CNE1000043R4.

Does aibio.space cover Guangzhou LBP Medicine Science & Technology Co.?

aibio.space lists Guangzhou LBP Medicine Science & Technology Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Guangzhou LBP Medicine Science & Technology Co.?

Companies in our directory listed in the same country and business area as Guangzhou LBP Medicine Science & Technology Co.: Hubei Goto Biopharm Group Co., Laekna, Hebei Changshan Biochemical Pharmaceutical Co., Fujian Haixi Pharmaceuticals Co., Medtide, Edding Genor Group Holdings.

Investor discussion: Guangzhou LBP Medicine Science & Technology Co.

Members talk about Guangzhou LBP Medicine Science & Technology Co. (688393). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688393 on TradingView.

Listing details

Guangzhou LBP Medicine Science & Technology Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688393, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Guangzhou LBP Medicine Science & Technology Co., Ltd.
Ticker
688393
Listing
SSE
Country or territory
China
Business scope
Biotechnology
ISIN
CNE1000043R4
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.